# Publications

Source: [https://yosephsamodra.com/publications/](https://yosephsamodra.com/publications/)

Last updated: 2026-10-24

---

## Identifiers

ORCID: [https://orcid.org/0000-0001-6000-0844](https://orcid.org/0000-0001-6000-0844)

Scopus: [https://www.scopus.com/authid/detail.uri?authorId=57363130700](https://www.scopus.com/authid/detail.uri?authorId=57363130700)

Web of Science ResearcherID: [https://www.webofscience.com/wos/author/record/IWU-9595-2023](https://www.webofscience.com/wos/author/record/IWU-9595-2023)

Google Scholar: [https://scholar.google.com/citations?user=dIqVL8AAAAAJ&hl=en](https://scholar.google.com/citations?user=dIqVL8AAAAAJ&hl=en)

LinkedIn: [https://www.linkedin.com/in/yosephsamodra/](https://www.linkedin.com/in/yosephsamodra/)

PubMed: [https://pubmed.ncbi.nlm.nih.gov/?term=yoseph+samodra](https://pubmed.ncbi.nlm.nih.gov/?term=yoseph+samodra)

ResearchGate: [https://www.researchgate.net/profile/Yoseph-Samodra](https://www.researchgate.net/profile/Yoseph-Samodra)

LiveDNA: [https://livedna.net/?dna=62.29813](https://livedna.net/?dna=62.29813)

### 2026

- Halim A, Sasongko DP, Wibowo NPA, Aminullah MR, Firmansyah AP, **Samodra YL**. Microplastics in atherosclerosis could exacerbate the cardiovascular risk: A systematic review. *BIO Web of Conferences*. 2026;255:03001. doi: 10.1051/bioconf/202625503001.

- Mahendra OA, **Samodra YL**, Widiantara INT. [Cesarean Section Patterns Based on the Robson Classification in a Regional General Hospital](https://yosephsamodra.com/cesarean-section-patterns-based-on-the-robson-classification-in-a-regional-general-hospital/). *Indonesian Journal of Obstetrics and Gynecology*. 2026;14(3):279-284. doi: 10.32771/inajog.v14i3.2954.

### 2025

- Sinaga BYM, Siregar J, Sormin DE, Sundari R, **Samodra YL**. Latent Tuberculosis Infection among Household Contacts of Drug-sensitive Pulmonary Tuberculosis Patients: A Cross-sectional Study from Medan, Indonesia. Acta Medica Philippina. 2025;59(19):84-90. doi: [10.47895/amp.vi0.10048](https://idebeasiswa.com/research-paper/latent-tuberculosis-infection-among-household-contacts-of-drug-sensitive-pulmonary-tuberculosis-patients-a-cross-sectional-study-from-medan-indonesia/).

- Tako FW, Sinaga BYM, Harahap J, Daulay RS, Siregar J, **Samodra YL**. Age and Diabetes Mellitus Associated with Hematological Disorders and Peripheral Neuropathy in MDR-TB Patients Treated with the BPaL/M Regimen. Jurnal Respirasi. 2025;11(3):241-249. doi: [10.20473/jr.v11-i.3.2025.241-249](https://idebeasiswa.com/research-paper/age-and-diabetes-mellitus-associated-with-hematological-disorders-and-peripheral-neuropathy-in-mdr-tb-patients-treated-with-the-bpal-m-regimen/).

- Amri IE, **Samodra YL**, Gupta I, Unim B. Systematic review of treatment options for gastric cancer and future therapeutic perspectives. Epidemiology, Biostatistics, and Public Health. 2025;20(2):1-22. doi: [10.54103/2282-0930/28332](https://idebeasiswa.com/research-paper/systematic-review-of-treatment-options-for-gastric-cancer-and-future-therapeutic-perspectives/).

- Mahendra OA, **Samodra YL**, Andampury FS. Characteristics of pediatric and adult tuberculosis cases at Pandak 1 Public Health Center, Bantul, 2020-2024. *Proceedings of the 6th Asian Conference on Science, Technology & Medicine*. 2025:11.

### 2024

- Rani HR, **Samodra YL**. Sphenopalatine block applications in cluster headache treatment. *Digital Journal of Science*. 2024;1(1):108.

- Sinaga JP, Sinaga BYM, Siagian P, Eyanoer PC, **Samodra YL**. Clinical spectrum and factors associated with post-COVID syndrome in healthcare workers. *Public Health of Indonesia*. 2024;10(4):1-14.

- **Samodra YL**, Chuang YC. [A growth curve model to estimate longitudinal effects of parental BMI on Indonesian children’s growth patterns](https://yosephsamodra.com/growth-curve-model-longitudinal-effects-of-parental-bmi-on-childrens-growth-patterns/). *Journal of Developmental Origins of Health and Disease*. 2024;15:e20:1-8.

- Prasetya RD, **Samodra YL**, Andampury FS. Risk factors for stunting in children aged 6-23 months in Pandak 1 Community Health Center. *Trends in Medical Research*. 2024;19(1):65-71.

- Sinaga BYM, Siagian P, Sinaga JP, **Samodra YL**. Fatigue in healthcare workers with mild COVID-19 survivors in Indonesia. *Narra J*. 2024;4(1):e656.

### 2023

- **Samodra YL**, Hsu HC, Chuang KY, Chuang YC. Family economic trajectories and body mass index in Indonesia: evidence from the Indonesian Family Life Surveys 2 to 5. *Preventive Medicine Reports*. 2023;34:102262.

### 2022

- **Samodra YL**, Pasaribu IRP, Kuntjoro I. Correlation between consumption pattern of caffeinated beverages and HDL level in elderlies in GKJ Gondokusuman Yogyakarta. *Journal of Medical Sciences*. 2022;22(1):8-12.

- **Samodra YL**, Chuang YC. Effects of parental economic level trajectories on children’s BMI Z-score trajectories in Indonesia. *Proceedings of the 6th International Nutrition and Health Symposium*. 2022:36-44.

- Ticoalu JHV, **Samodra YL**, Huy LD. Limitations in daily activities as the strongest predictor of pharmacotherapy usage for pain in Indonesia. *Proceedings of the 4th Indonesian Scholars Scientific Summit*. 2022:116-121.

### 2021

- **Samodra YL**, Wijaya OH. Plant-based diet to prevent coronary artery disease. *World Journal of Food and Nutrition*. 2021;1(2):1006.

- Marpaung RVP, **Samodra YL**, Harjosuwarno SS. Hubungan pola asuh terhadap status gizi pada anak TK di Kota Yogyakarta. *Jurnal Ilmiah Kesehatan Media Husada*. 2021;10(1):1-9.

### 2020

- Putra DK, **Samodra YL**, Nugroho DCA. Hubungan Pola Konsumsi Minuman Berkafein dengan Fungsi Kognitif pada Lansia di GKJ Gondokusuman Yogyakarta. e-CliniC. 2020;8(2):251-258. doi: [10.35790/ecl.v8i2.31432](https://idebeasiswa.com/research-paper/hubungan-pola-konsumsi-minuman-berkafein-dengan-fungsi-kognitif-pada-lansia-di-gkj-gondokusuman-yogyakarta/).

- Sitompul SO, **Samodra YL**, Kuntjoro I. Hubungan Pola Makan Anak dengan Status Gizi Siswa TK Bopkri Gondokusuman Yogyakarta. Indonesian Journal of Nursing Health Science. 2020;5(2):126-133. doi: [10.47007/ijnhs.v5i2.3312](https://idebeasiswa.com/research-paper/hubungan-pola-makan-anak-dengan-status-gizi-siswa-tk-bopkri-gondokusuman-yogyakarta/).

- Pradana Y, Indrarto FXW, Merry MS, **Samodra YL**. Clinical Characteristics of Paediatric Measles Patients at Mojowarno Christian Hospital, Jombang, in 2015-2016. Berkala Ilmiah Kedokteran Duta Wacana. 2020;5(1):16-21. doi: [10.21460/bikdw.v5i1.139](https://idebeasiswa.com/research-paper/clinical-characteristics-of-paediatric-measles-patients-at-mojowarno-christian-hospital-jombang-in-2015-2016/).

### 2019

- Rosario AM, **Samodra YL**, Suryanto YI. Kebiasaan Sarapan Berhubungan dengan Tingkat Kebugaran Jasmani pada Anak Usia Sekolah Dasar di SD Budya Wacana Yogyakarta. Indonesian Journal of Human Nutrition. 2019;6(2):139-144. doi: [10.21776/ub.ijhn.2019.006.02.7](https://idebeasiswa.com/research-paper/kebiasaan-sarapan-berhubungan-dengan-tingkat-kebugaran-jasmani-pada-anak-usia-sekolah-dasar-di-sd-budya-wacana-yogyakarta/).

- Wibawa PGSS, Indrarto FXW, **Samodra YL**. Protective Effect of Exclusive Breastfeeding on Acute Respiratory Infections (ARI) among Children in Tabanan, Bali. Journal of Health Education. 2019;4(2):65-71. doi: [10.15294/jhe.v4i2.29630](https://idebeasiswa.com/research-paper/protective-effect-of-exclusive-breastfeeding-on-acute-respiratory-infections-ari-among-children-in-tabanan-bali/).

- Nahak ADN, **Samodra YL**, Kuntjoro I. History of Fish-Based Complementary Food Provision Toward Children’s Cognitive Level in Elementary School. Journal of Health Education. 2019;4(1):1-7. doi: [10.15294/jhe.v4i1.29378](https://idebeasiswa.com/research-paper/history-of-fish-based-complementary-food-provision-toward-childrens-cognitive-level-in-elementary-school/).

### 2018

- **Samodra YL**, Rahmawati NT, Sumarni S. Faktor-faktor yang mempengaruhi kemampuan kognitif pada lansia obesitas di Indonesia. Jurnal Gizi Klinik Indonesia. 2018;14(4):154-162. doi: [10.22146/ijcn.25765. ;10(1):1-9](https://idebeasiswa.com/research-paper/faktor-faktor-yang-mempengaruhi-kemampuan-kognitif-pada-lansia-obesitas-di-indonesia/).

## Global Burden of Disease Collaborative Publications

### 2026

- GBD 2023 Diarrhoeal Disease and Enteric Infectious Diseases Collaborators. Global burden of enteric infectious diseases, diarrhoeal diseases, and corresponding aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. *The Lancet Infectious Diseases*. 2026. In press.

- GBD 2023 Childhood Cancer Collaborators. Global burden of cancer in children and adolescents aged 0-19 years, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. *The Lancet*. 2026;407:1360-1373.

- GBD 2023 Breast Cancer Collaborators. Global, regional, and national burden of breast cancer among females, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. *The Lancet Oncology*. 2026;27:302-326.

- GBD 2023 Meningitis & Antimicrobial Resistance Collaborators. Global, regional, and national burden of meningitis, its risk factors, and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. *The Lancet Neurology*. 2026;25:451-468.

- GBD 2023 Maternal Mortality Collaborators. Global, regional, and national levels and trends in maternal mortality, progress towards the Sustainable Development Goals, and mortality from COVID-19 infection in pregnant women, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. *The Lancet Obstetrics, Gynaecology, & Women’s Health*. 2026;2:e375-e424.

- GBD 2023 Lower Respiratory Infections and Antimicrobial Resistance Collaborators. Global burden of lower respiratory infections and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. *The Lancet Infectious Diseases*. 2026;26:343-361.

- GBD 2021 AEMT Collaborators. Global burden of adverse effects of medical treatment from 1990 to 2021: a Global Burden of Disease Study 2021. *The Korean Journal of Internal Medicine*. 2026;41(2):350-366.

- GBD 2023 Child Growth Failure Collaborators. Quantifying the fatal and non-fatal burden of disease associated with child growth failure, 2000-2023: a systematic analysis from the Global Burden of Disease Study 2023. *The Lancet Child & Adolescent Health*. 2026;10:22-38.

- GBD 2023 Asia Chronic Respiratory Disease Collaborators. Burden of chronic respiratory disease in Asia, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. *The Lancet Respiratory Medicine*. 2026;14:233-255.

- Vision Loss Expert Group of the Global Burden of Disease Study and GBD 2019 Blindness and Vision Impairment Collaborators. Prevalence of vision loss in East Asia from 1990 to 2020: magnitude and temporal trends. *Ophthalmic Epidemiology*. 2026;33(1):68-76.

### 2025

- Cenderadewi M, Devine SG, Peden AE, Franklin RC, GBD 2019 Indonesia Drowning Collaborators. Burden of unintentional drowning in Indonesia: insights from the Global Burden of Disease Study 2019. *Injury Prevention*. 2025;31:508-517.

- GBD 2023 Chronic Kidney Disease Collaborators. Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023. *The Lancet*. 2025;406:2461-2482.

- GBD 2021 Global Sepsis Collaborators. Global, regional, and national sepsis incidence and mortality, 1990-2021: a systematic analysis. *The Lancet Global Health*. 2025;13:e2013-e2026.

- GBD 2023 Demographics Collaborators. Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023. *The Lancet*. 2025;406:1731-1810.

- GBD 2023 Causes of Death Collaborators. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. *The Lancet*. 2025;406:1811-1872.

- GBD 2023 Disease and Injury and Risk Factor Collaborators. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. *The Lancet*. 2025;406:1873-1922.

- GBD 2023 Cancer Collaborators. The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. *The Lancet*. 2025;406:1565-1586.

- GBD 2021 Low Bone Mineral Density Collaborators. The global, regional, and national burden attributable to low bone mineral density, 1990-2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021. *The Lancet Rheumatology*. 2025;7:e873-e894.

- GBD 2023 Kidney Failure with Replacement Therapy Collaborators. Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. *The Lancet Global Health*. 2025;13:e1378-e1395.

- Zhang C, Yang X, Wan D, Ma Q, Yin P, GBD 2021 China Neurological Disorders Collaborators, Zhou M, Hao J. Burden of neurological disorders in China and its provinces, 1990-2021: findings from the Global Burden of Disease Study 2021. *Med*. 2025;6:100692.

- GBD 2021 Global AMD Collaborators. Global burden of vision impairment due to age-related macular degeneration, 1990-2021, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021. *The Lancet Global Health*. 2025;13:e1175-e1190.

- GBD 2021 Asia Allergic Disorders Collaborators. Asthma and atopic dermatitis in Asia, 1990-2021: the Global Burden of Disease Study 2021. *Clinical & Experimental Allergy*. 2025;55:671-690.

- GBD 2021 ASEAN Injuries Collaborators. The epidemiology and burden of injury in countries of the Association of Southeast Asian Nations, 1990-2021: findings from the Global Burden of Disease Study 2021. *The Lancet Public Health*. 2025;10:e456-e466.

- GBD 2021 ASEAN Mental Disorders Collaborators. The epidemiology and burden of ten mental disorders in countries of the Association of Southeast Asian Nations, 1990-2021: findings from the Global Burden of Disease Study 2021. *The Lancet Public Health*. 2025;10:e480-e491.

- GBD 2021 ASEAN Cardiovascular Diseases Collaborators. The epidemiology and burden of cardiovascular diseases in countries of the Association of Southeast Asian Nations, 1990-2021: findings from the Global Burden of Disease Study 2021. *The Lancet Public Health*. 2025;10:e467-e479.

- GBD 2023 Vaccine Coverage Collaborators. Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023. *The Lancet*. 2025;406:235-260.

- GBD 2021 Global Subarachnoid Hemorrhage Risk Factors Collaborators. Global, regional, and national burden of nontraumatic subarachnoid hemorrhage: the Global Burden of Disease Study 2021. *JAMA Neurology*. 2025;82(8):765-787.

- GBD 2019 Acute and Chronic Care Collaborators. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019. *Nature Communications*. 2025;16:4235.

- Lee S, Son Y, Hwang J, Kim MS, GBD 2021 Dietary Iron Deficiency Collaborators, Shin JI, Yon DK, Kassebaum NJ. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study. *Nature Medicine*. 2025;31:1809-1829.

- GBD 2021 Asthma and Allergic Diseases Collaborators. Global, regional, and national burden of asthma and atopic dermatitis, 1990-2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. *The Lancet Respiratory Medicine*. 2025;13:425-446.

- GBD 2021 Adult BMI Collaborators. Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. *The Lancet*. 2025;405:813-838.

- GBD Epilepsy Collaborators. Global, regional, and national burden of epilepsy, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. *The Lancet Public Health*. 2025;10:e203-e227.

### 2024

- GBD 2021 Diarrhoeal Diseases Collaborators. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990-2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021. *The Lancet Infectious Diseases*. 2025;25:519-536. Published online in 2024.

- GBD 2021 Stroke Risk Factor Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. *The Lancet Neurology*. 2024;23:973-1003.

- GBD 2021 Tobacco Forecasting Collaborators. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021. *The Lancet Public Health*. 2024;9:e729-e744.

- GBD 2021 Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050. *The Lancet*. 2024;404:1199-1226.

- GBD 2021 Upper Respiratory Infections and Otitis Media Collaborators. Global, regional, and national burden of upper respiratory infections and otitis media, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021. *The Lancet Infectious Diseases*. 2025;25:36-51. Published online in 2024.

- GBD 2019 MSK in Adolescents Collaborators. Global pattern, trend, and cross-country inequality of early musculoskeletal disorders from 1990 to 2019, with projection from 2020 to 2050. *Med*. 2024;5:943-962.e6.

- Vision Loss Expert Group of the Global Burden of Disease Study and GBD 2019 Blindness and Vision Impairment Collaborators. Global estimates on the number of people blind or visually impaired by uncorrected refractive error: a meta-analysis from 2000 to 2020. *Eye*. 2024;38(11):2083-2101.

- Vision Loss Expert Group of the Global Burden of Disease Study and GBD 2019 Blindness and Vision Impairment Collaborators. Global estimates on the number of people blind or visually impaired by age-related macular degeneration: a meta-analysis from 2000 to 2020. *Eye*. 2024;38:2070-2082.

- GBD 2021 Forecasting Collaborators. Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021. *The Lancet*. 2024;403:2204-2256.

- GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. *The Lancet*. 2024;403(10440):2162-2203.

- GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability, disability-adjusted life-years, and healthy life expectancy for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. *The Lancet*. 2024;403(10440):2133-2161.

- GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators. Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021. *The Lancet Infectious Diseases*. 2024;24:974-1002.

- GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. *The Lancet*. 2024;403:2100-2132.

- GBD 2021 Fertility and Forecasting Collaborators. Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. *The Lancet*. 2024;403(10440):2057-2099.

- GBD 2021 Tuberculosis Collaborators. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021. *The Lancet Infectious Diseases*. 2024;24:698-725.

- GBD 2021 Nervous System Disorders Collaborators. Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. *The Lancet Neurology*. 2024;23(4):344-381.

- GBD 2021 Demographics Collaborators. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. *The Lancet*. 2024;403(10440):1989-2056.

- Vision Loss Expert Group of the Global Burden of Disease Study and GBD 2019 Blindness and Vision Impairment Collaborators. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020. *Eye*. 2024;38:2156-2172.

### 2022

- GBD 2019 Indonesia Subnational Collaborators. The state of health in Indonesia’s provinces, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. *The Lancet Global Health*. 2022;10(11):e1632-e1645.

- GBD 2019 Cancer Risk Factors Collaborators. The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019. *The Lancet*. 2022;400(10352):563-591.

### 2021

- GBD 2019 Under-5 Mortality Collaborators. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019. *The Lancet*. 2021;398(10303):870-905.
